Rafferty Asset Management, LLC Vaxcyte, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 64,496 shares of PCVX stock, worth $5.91 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

64,496

Previous 94,683 31.88%

Holding current value

$5.91 Million

Previous $7.15 Million 2.99%

% of portfolio

0.03%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$70.52 - $117.12 $2.13 Million - $3.54 Million	-30,187 Reduced 31.88%	64,496 $7.36 Million
Q2 2024 Aug 13, 2024	SELL	$60.06 - $78.77 $1.89 Million - $2.48 Million	-31,481 Reduced 24.95%	94,683 $7.15 Million
Q1 2024 May 13, 2024	SELL	$59.79 - $81.05 $1.93 Million - $2.61 Million	-32,249 Reduced 20.36%	126,164 $8.62 Million
Q4 2023 Feb 13, 2024	SELL	$45.35 - $63.41 $248,563 - $347,550	-5,481 Reduced 3.34%	158,413 $9.95 Million
Q3 2023 Nov 13, 2023	SELL	$46.0 - $53.1 $19,090 - $22,036	-415 Reduced 0.25%	163,894 $8.36 Million
Q2 2023 Aug 11, 2023	SELL	$34.66 - $54.07 $539,725 - $841,978	-15,572 Reduced 8.66%	164,309 $8.21 Million
Q1 2023 May 11, 2023	SELL	$36.27 - $47.2 $377,969 - $491,871	-10,421 Reduced 5.48%	179,881 $6.74 Million
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $1.99 Million - $4.65 Million	96,889 Added 103.72%	190,302 $9.12 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $911,630 - $1.2 Million	42,030 Added 81.8%	93,413 $2.24 Million
Q2 2022 Aug 12, 2022	SELL	$17.68 - $26.58 $117,837 - $177,155	-6,665 Reduced 11.48%	51,383 $1.12 Million
Q1 2022 May 13, 2022	BUY	$17.46 - $26.36 $205,888 - $310,837	11,792 Added 25.49%	58,048 $1.4 Million
Q4 2021 Feb 10, 2022	BUY	$19.32 - $26.45 $351,179 - $480,781	18,177 Added 64.74%	46,256 $1.1 Million
Q3 2021 Nov 10, 2021	SELL	$20.26 - $26.97 $502,995 - $669,584	-24,827 Reduced 46.93%	28,079 $712,000
Q2 2021 Aug 10, 2021	SELL	$16.45 - $24.06 $623,076 - $911,320	-37,877 Reduced 41.72%	52,906 $1.19 Million
Q1 2021 May 10, 2021	BUY	$18.66 - $29.16 $1.53 Million - $2.38 Million	81,771 Added 907.36%	90,783 $1.79 Million
Q4 2020 Feb 10, 2021	BUY	$26.57 - $51.74 $239,448 - $466,280	9,012 New	9,012 $239,000

Others Institutions Holding PCVX

# of Institutions

354

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.43B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Vaxcyte, Inc. Transaction History